8-K filings / November 18, 2026
IMPACT BIOMEDICAL INC.: A stock exchange listing notice
IMPACT BIOMEDICAL INC. filed a current report (Form 8-K) with the SEC on November 18, 2026. It reports a stock exchange listing notice.
Item 3.01
Stock exchange listing notice
-
Exchange
NYSE American
From the filing
Source
“On the Closing Date, the Company notified NYSE American that the Merger had been completed and requested that NYSE American (i) suspend trading of the Company Common Stock prior to the open of trading on November 18, 2026, (ii) withdraw the Company’s Common Stock from listing on NYSE American, and (iii) file with the SEC a notification of removal from listing on Form 25 to delist the Company Common Stock from NYSE American and deregister the Company Common Stock under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).”
Read by code from this sentence of the filing. -
What it says
The stock leaves the exchange after a merger
From the filing
Source
“On the Closing Date, the Company notified NYSE American that the Merger had been completed and requested that NYSE American (i) suspend trading of the Company Common Stock prior to the open of trading on November 18, 2026, (ii) withdraw the Company’s Common Stock from listing on NYSE American, and (iii) file with the SEC a notification of removal from listing on Form 25 to delist the Company Common Stock from NYSE American and deregister the Company Common Stock under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).”
Read by code from this sentence of the filing. -
Notice date
November 18, 2026
From the filing
Source
“On the Closing Date, the Company notified NYSE American that the Merger had been completed and requested that NYSE American (i) suspend trading of the Company Common Stock prior to the open of trading on November 18, 2026, (ii) withdraw the Company’s Common Stock from listing on NYSE American, and (iii) file with the SEC a notification of removal from listing on Form 25 to delist the Company Common Stock from NYSE American and deregister the Company Common Stock under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).”
Read by code from this sentence of the filing.
Not investment advice.Read the filing on SEC.gov
Item 5.02
Officers and directors
The filing also carries this item, but our code could not read it surely, so its facts are not shown here.
Not investment advice.Read the filing on SEC.gov
Facts read from the filing's own text; a fact the filing does not state clearly is left out. All documents of this filing on SEC.gov.